Welch William P, Sitwat Bilal, Sogawa Yoshimi
1 Division of Pediatric Neurology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA.
J Child Neurol. 2018 Jun;33(7):449-452. doi: 10.1177/0883073818766599. Epub 2018 Apr 13.
To describe the response to vagus nerve stimulator (VNS) in otherwise neurotypical children with medically intractable primary generalized epilepsy.
Retrospective chart review of patients who underwent vagus nerve stimulator surgery between January 2011 and December 2015.
Eleven patients were identified. Median follow-up duration was 2.5 years (1.2-8.4 years). Prior to vagus nerve stimulator surgery, all patients had at least 1 seizure per week, and 7/11 (64%) had daily seizures. At 1-year follow-up after vagus nerve stimulator, 7/11 (64%) reported improved seizure frequency and 6/11 (55%) reported fewer than 1 seizure per month. Three patients (27%) reported complications related to vagus nerve stimulator surgery, and no patients required device removal.
In children with medically intractable primary generalized epilepsy, vagus nerve stimulator is well tolerated and appears to lead to improvement in seizure frequency. Improvement was not attributable to epilepsy classification, age at vagus nerve stimulator implantation, output current, duty cycle, or follow-up duration.
描述迷走神经刺激器(VNS)对其他方面神经发育正常但患有药物难治性原发性全身性癫痫的儿童的反应。
对2011年1月至2015年12月期间接受迷走神经刺激器手术的患者进行回顾性病历审查。
共确定了11名患者。中位随访时间为2.5年(1.2 - 8.4年)。在进行迷走神经刺激器手术前,所有患者每周至少发作1次癫痫,11名患者中有7名(64%)每天发作癫痫。在迷走神经刺激器植入术后1年的随访中,11名患者中有7名(64%)报告癫痫发作频率有所改善,11名患者中有6名(55%)报告每月癫痫发作少于1次。3名患者(27%)报告了与迷走神经刺激器手术相关的并发症,且无患者需要移除装置。
在患有药物难治性原发性全身性癫痫的儿童中,迷走神经刺激器耐受性良好,且似乎能使癫痫发作频率得到改善。这种改善与癫痫分类、迷走神经刺激器植入时的年龄、输出电流、占空比或随访时间无关。